Which is not a serotonin-norepinephrine reuptake inhibitor
Core Concept: SNRIs block reuptake of both serotonin and norepinephrine. The question is testing knowledge of antidepressant classification.
Why Correct Answer is Right: Reboxetine is an NRI, not an SNRI. It only affects norepinephrine. So if the correct answer is Reboxetine, then that's the one not an SNRI.
Incorrect Options: SSRIs like fluoxetine (inhibits only serotonin), TCAs like amitriptyline (block both but via different mechanisms), or maybe even SSRIs. Also, maybe SNRIs like venlafaxine would be distractors. Need to check each option.
Clinical Pearl: Remember SNRIs vs NRIs. Reboxetine is a pure NRI, so it's a common exam trap. High-yield to distinguish these.
**Core Concept**
Serotonin-norepinephrine reuptake inhibitors (SNRIs) block the reuptake of both serotonin and norepinephrine, enhancing neurotransmission in the central nervous system. This mechanism is crucial in treating depression and anxiety disorders.
**Why the Correct Answer is Right**
**Reboxetine** is a selective norepinephrine reuptake inhibitor (NRI), not an SNRI. It exclusively inhibits norepinephrine reuptake via the norepinephrine transporter (NET), without significant serotonin reuptake inhibition. This distinguishes it from SNRIs like venlafaxine or duloxetine, which target both serotonin and norepinephrine transporters.
**Why Each Wrong Option is Incorrect**
**Option A:** *Venlafaxine* is a prototypical SNRI, inhibiting both serotonin and norepinephrine reuptake.
**Option B:** *Duloxetine* is another SNRI used for major depression and neuropathic pain.
**Option C:** *Milnacipran* is an SNRI indicated for fibromyalgia and depression.
**Option D:** *Fluoxetine* is a selective serotonin reupt